Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center.
ILUVIEN
OZURDEX
dexamethasone
fluocinolone intravitreal implant
intraocular inflammation
macular edema
non-infectious uveitis
pars plana vitrectomy (PPV)
sustained release corticosteroid
visual acuity
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
16 May 2024
16 May 2024
Historique:
received:
04
04
2024
revised:
08
05
2024
accepted:
10
05
2024
medline:
25
5
2024
pubmed:
25
5
2024
entrez:
25
5
2024
Statut:
epublish
Résumé
Macular edema (ME) remains a primary cause of visual deterioration in uveitis. Visual acuity (VA) can often be maintained using corticosteroid depot systems. This study evaluated the efficacy of a fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN
Identifiants
pubmed: 38791073
pii: biomedicines12051106
doi: 10.3390/biomedicines12051106
pii:
doi:
Types de publication
Journal Article
Langues
eng